I'm hoping for a buyout of the company at between $150-300 mill. Individual sales of ArtiMist or other may be more beneficial to shareholders, but I have no idea of pricing! Why wouldn't a large pharma consider buying the potential of all the Suda products?
Artimist, page-4
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.005(3.45%) |
Mkt cap ! $157.7M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 15.0¢ | 14.5¢ | $22.86K | 154.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 525619 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 327800 | 6 |
View Market Depth
| Last trade - 10.17am 11/09/2024 (20 minute delay) ? |
| ALA (ASX) Chart |